Global Blood Therapeutics (GBT) broke out to new highs last week and remains strong today. Let's check out the charts of this clinical-stage biopharmaceutical company.
More from Investing
If you focus on the following four traits, you are well on your way to trading success.
With a business model very different from that of most cloud/SaaS peers, it took a while for markets to appreciate Dropbox's long-term value.
The question is whether this is just another flash in the pan or a change in market character.